Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TRPH-222 |
Trade Name | |
Synonyms | TRPH222|TRPH 222 |
Drug Descriptions |
TRPH-222 is an antibody-drug conjugate that consists of a CD22 antibody linked to a maytansinoid payload, which may inhibit tumor growth (Cancer Res 2018;78(13 Suppl):Abstract nr 835). |
DrugClasses | CD22 Immune Cell Therapy 15 |
CAS Registry Number | NA |
NCIT ID | C156882 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TRPH-222 | TRPH-222 | 0 | 1 |